Results 61 to 70 of about 47,980 (197)
Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide
, 2017 Mario Cozzolino,1 Andrea Galassi,1 Ferruccio Conte,1 Michela Mangano,1 Luca Di Lullo,2 Antonio Bellasi1,3 1Department of Health Sciences, Renal Division, University of Milan, ASST Santi Paolo e Carlo, San Paolo Hospital, Milan, 2U.O.C.
Mangano M +5 more
core
World Journal of Otorhinolaryngology - Head and Neck Surgery, Volume 12, Issue 3, Page 346-352, June 2026.ABSTRACT Purpose This study aimed to describe the initial experience with robot‐assisted transaxillary parathyroidectomy (RATP) and to investigate its safety and efficacy as a surgical approach for the treatment of primary hyperparathyroidism (PHPT).
Xi‐Jun Lin +7 more
wiley +1 more source
Hypercalcaemia and primary hyperparathyroidism
, 2005 Hypercalcaemia has many potential causes, but in everyday clinical practice, primary hyperparathyroidism is the most common cause in out-patients and malignancy the most common in in-patients.
Hatfield, Emma, Turner, Jeremy
core +1 more source
Echocardiography, Volume 43, Issue 6, June 2026.Patients with symptomatic primary hyperparathyroidism (PHPT) have increased cardiovascular risk related to biochemical abnormalities and structural cardiac changes. We performed a meta‑analysis of 24 studies (881 patients) to evaluate echocardiographic changes following parathyroidectomy. Global longitudinal strain significantly improved after surgery,
Arsalan Anees +2 more
wiley +1 more source
Primary hyperparathyroidism in pregnancy [PDF]
Primary hyperparathyroidism is a disorder, in which parathormone is secreted excessively and it is associated with hypercalcemia. The cause of primary hyperparathyroidism is seen in 85% of parathyroid adenoma cases, in 4% of multiple adenoma cases, and ...
ذاکری, آناهیتا +4 more
core
European Journal of Clinical Investigation, Volume 56, Issue 6, June 2026.ABSTRACT Background/Aims Metabolic bariatric surgery remains the most potent weapon we have against severe obesity and its metabolic consequences. Yet, its effects on the liver are far from uniform. Although restrictive and mixed procedures like sleeve gastrectomy and Roux‐en‐Y gastric bypass consistently improve metabolic dysfunction‐associated ...
Francesco Saverio Papadia +3 more
wiley +1 more source
Breast cancer associated with primary hyperparathyroidism: A nested case control study
, 2011 Sophie Norenstedt1,7, Fredrik Granath2, Anders Ekbom2, Jonas Bergh3, Mats Lambe4, Jan Adolfsson5, Fredrik Warnberg6, Jan Zedenius1,7, Inga-Lena Nilsson1,71Department of Molecular Medicine and Surgery, 2Department of Medicine, 3Department of Oncology and ...
Norenstedt S, Granath F, Ekbom A +1 more
core
Nephrology, Volume 31, Issue 6, June 2026.This study from the THAI‐CKD registry evaluated regional and KDIGO‐based variations in chronic kidney disease (CKD) aetiologies and complications among 3371 adults with CKD G3‐G5 across six regions of Thailand. Diabetic nephropathy was the leading aetiology, followed by hypertensive nephrosclerosis and CKD of unknown aetiology.
Kavita Jintanapramote +23 more
wiley +1 more source
, 2018 Takashi Shigematsu,1 Ryutaro Shimazaki,2 Masafumi Fukagawa,3 Tadao Akizawa4 On behalf of the Evocalcet Study Group 1Department of Nephrology, Wakayama Medical University, Wakayama, Japan; 2R&D Division, Kyowa Hakko Kirin Co., Ltd., Chiyoda-ku, Tokyo,
Shigematsu T +3 more
core
Quantification of SARM1 NADase Activity in Human Peripheral Blood Mononuclear Cells
The FASEB Journal, Volume 40, Issue 9, 15 May 2026.Proposed model for NAD+ metabolism in (A) control and (B) SARM1 activated PBMCs. In native form, 3‐AP and Vacor compete with NAM as an alternative substrate for NAMPT. This consequently decreases generation of NMN and biosynthesis of NAD+ is limited by both a reduction in precursor NMN and direct inhibition of NMNAT by Vacor‐MN and 3‐AP‐MN.
Lila F. Dabill +5 more
wiley +1 more source